Helping the Community and the World One Patient at a Time

  • Home
  • Enrolling Trials
  • About Us
  • FAQ
  • Contact Us
  • Research Prospective
  • Our Investigators
  • Novartis Exchange
  • More
    • Home
    • Enrolling Trials
    • About Us
    • FAQ
    • Contact Us
    • Research Prospective
    • Our Investigators
    • Novartis Exchange
  • Home
  • Enrolling Trials
  • About Us
  • FAQ
  • Contact Us
  • Research Prospective
  • Our Investigators
  • Novartis Exchange

Geodyssey Research, LLC

Geodyssey Research, LLCGeodyssey Research, LLCGeodyssey Research, LLC

Located in Vero Beach, Florida

Located in Vero Beach, FloridaLocated in Vero Beach, FloridaLocated in Vero Beach, Florida

Current Enrolling Clinical Trials

Contact Us for Additional Information

VERISMO

BA39731  Phase 4  An Observational Study Of Ocrelizumab Patients With Multiple Sclerosis To Determine the Incidence And Mortality Rates Of Breast  Cancer and All Malignancies (VERISMO STUDY)

Celgene /Bristol Myers Squibb ENLIGHTEN

A Multicenter, Longitudinal, Open-Label, Single -Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod (RPC-1063)

Find out more

Lundbeck NA, Ltd.

A Clinical study of Patients with Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy.

Find out more

Novartis - Exchange

Exploring the safety and tolerability of conversion from oral or injectable disease modifying therapies to dose titrated Oral Siponimod in patients with advancing forms of  relapsing multiple sclerosis

Find out more

EMD - Serono

The study will evaluate the efficacy and safety of evobrutinib administered orally twice daily versus Interferon-beta-1a (Avonex®), once a week intramuscularly in participants with Relapsing Multiple Sclerosis (RMS).
 

Find out more

Display their FAQs

Customers have questions, you have answers. Display the most frequently asked questions, so everybody benefits.

Current enrolling clinical trials

ADDEX ADX48621

  ADX48621-301A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group,  Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of  ADX48621 in the Treatment of Levodopa Induced Dyskinesia in Patients  With Parkinson's Disease  

Genentech Inc.

Genentech WA40404

A phase IIIb multi-center, randomized double-blind, placebo controlled study to evaluate the efficacy and safety of Ocrelizumab in adults with primary progressive multiple sclerosis.


Find out more

ROCHE - FENtrepid

 GN41791   A phase lll Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy and Safety of Fenebrutinib Compared With Primary Progressive Multiple Sclerosis 


Copyright © 2019 Geodyssey Research LLC - All Rights Reserved.